nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—Cholangitis—Thalidomide—leprosy	0.048	0.048	CcSEcCtD
Entacapone—Consciousness abnormal—Thalidomide—leprosy	0.048	0.048	CcSEcCtD
Entacapone—Albuminuria—Dapsone—leprosy	0.0218	0.0218	CcSEcCtD
Entacapone—Dementia—Thalidomide—leprosy	0.0203	0.0203	CcSEcCtD
Entacapone—Fungal skin infection—Thalidomide—leprosy	0.0199	0.0199	CcSEcCtD
Entacapone—Parkinsonism—Thalidomide—leprosy	0.0183	0.0183	CcSEcCtD
Entacapone—Altered state of consciousness—Thalidomide—leprosy	0.018	0.018	CcSEcCtD
Entacapone—White blood cell count decreased—Thalidomide—leprosy	0.0167	0.0167	CcSEcCtD
Entacapone—Sexual dysfunction—Thalidomide—leprosy	0.0149	0.0149	CcSEcCtD
Entacapone—Foetor hepaticus—Thalidomide—leprosy	0.0147	0.0147	CcSEcCtD
Entacapone—Serum creatinine increased—Thalidomide—leprosy	0.0135	0.0135	CcSEcCtD
Entacapone—Tooth disorder—Thalidomide—leprosy	0.0128	0.0128	CcSEcCtD
Entacapone—Liver disorder—Thalidomide—leprosy	0.0122	0.0122	CcSEcCtD
Entacapone—Psychotic disorder—Dapsone—leprosy	0.0115	0.0115	CcSEcCtD
Entacapone—Albuminuria—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Entacapone—Muscular weakness—Dapsone—leprosy	0.0104	0.0104	CcSEcCtD
Entacapone—Myocardial ischaemia—Thalidomide—leprosy	0.0104	0.0104	CcSEcCtD
Entacapone—Numbness—Thalidomide—leprosy	0.01	0.01	CcSEcCtD
Entacapone—Endocrine disorder—Thalidomide—leprosy	0.01	0.01	CcSEcCtD
Entacapone—Sensory loss—Thalidomide—leprosy	0.00961	0.00961	CcSEcCtD
Entacapone—Musculoskeletal stiffness—Thalidomide—leprosy	0.00928	0.00928	CcSEcCtD
Entacapone—Hyperbilirubinaemia—Thalidomide—leprosy	0.00916	0.00916	CcSEcCtD
Entacapone—Thinking abnormal—Thalidomide—leprosy	0.0091	0.0091	CcSEcCtD
Entacapone—Herpes simplex—Thalidomide—leprosy	0.00904	0.00904	CcSEcCtD
Entacapone—Neuropathy peripheral—Dapsone—leprosy	0.00892	0.00892	CcSEcCtD
Entacapone—Dyskinesia—Thalidomide—leprosy	0.00886	0.00886	CcSEcCtD
Entacapone—Hypercholesterolaemia—Thalidomide—leprosy	0.00881	0.00881	CcSEcCtD
Entacapone—Sinusitis—Dapsone—leprosy	0.00854	0.00854	CcSEcCtD
Entacapone—Gait disturbance—Thalidomide—leprosy	0.00853	0.00853	CcSEcCtD
Entacapone—Phosphatase alkaline increased—Thalidomide—leprosy	0.00833	0.00833	CcSEcCtD
Entacapone—Hepatocellular injury—Thalidomide—leprosy	0.00833	0.00833	CcSEcCtD
Entacapone—Pharyngitis—Dapsone—leprosy	0.00811	0.00811	CcSEcCtD
Entacapone—Colitis—Thalidomide—leprosy	0.008	0.008	CcSEcCtD
Entacapone—Cramps of lower extremities—Thalidomide—leprosy	0.00765	0.00765	CcSEcCtD
Entacapone—Oesophagitis—Thalidomide—leprosy	0.00761	0.00761	CcSEcCtD
Entacapone—Rash maculo-papular—Thalidomide—leprosy	0.00757	0.00757	CcSEcCtD
Entacapone—Hyperkinesia—Thalidomide—leprosy	0.00726	0.00726	CcSEcCtD
Entacapone—Mental disability—Thalidomide—leprosy	0.00723	0.00723	CcSEcCtD
Entacapone—Euphoric mood—Thalidomide—leprosy	0.00716	0.00716	CcSEcCtD
Entacapone—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00695	0.00695	CcSEcCtD
Entacapone—Gastroenteritis—Thalidomide—leprosy	0.00682	0.00682	CcSEcCtD
Entacapone—Vascular purpura—Thalidomide—leprosy	0.00676	0.00676	CcSEcCtD
Entacapone—Eczema—Thalidomide—leprosy	0.00673	0.00673	CcSEcCtD
Entacapone—Vision blurred—Dapsone—leprosy	0.0067	0.0067	CcSEcCtD
Entacapone—Injury—Thalidomide—leprosy	0.00658	0.00658	CcSEcCtD
Entacapone—Vertigo—Dapsone—leprosy	0.00639	0.00639	CcSEcCtD
Entacapone—Atrial fibrillation—Thalidomide—leprosy	0.00638	0.00638	CcSEcCtD
Entacapone—Dermatitis bullous—Thalidomide—leprosy	0.00633	0.00633	CcSEcCtD
Entacapone—Purpura—Thalidomide—leprosy	0.00627	0.00627	CcSEcCtD
Entacapone—Arthritis—Thalidomide—leprosy	0.00622	0.00622	CcSEcCtD
Entacapone—Cough—Dapsone—leprosy	0.00621	0.00621	CcSEcCtD
Entacapone—Hypoglycaemia—Thalidomide—leprosy	0.00619	0.00619	CcSEcCtD
Entacapone—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00605	0.00605	CcSEcCtD
Entacapone—Pain in extremity—Thalidomide—leprosy	0.00605	0.00605	CcSEcCtD
Entacapone—Diplopia—Thalidomide—leprosy	0.00605	0.00605	CcSEcCtD
Entacapone—Disturbance in sexual arousal—Thalidomide—leprosy	0.006	0.006	CcSEcCtD
Entacapone—Psychotic disorder—Thalidomide—leprosy	0.0059	0.0059	CcSEcCtD
Entacapone—Ataxia—Thalidomide—leprosy	0.00568	0.00568	CcSEcCtD
Entacapone—Blood creatinine increased—Thalidomide—leprosy	0.00566	0.00566	CcSEcCtD
Entacapone—Orthostatic hypotension—Thalidomide—leprosy	0.00552	0.00552	CcSEcCtD
Entacapone—Cramp muscle—Thalidomide—leprosy	0.00544	0.00544	CcSEcCtD
Entacapone—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00544	0.00544	CcSEcCtD
Entacapone—Muscular weakness—Thalidomide—leprosy	0.00533	0.00533	CcSEcCtD
Entacapone—Insomnia—Dapsone—leprosy	0.00525	0.00525	CcSEcCtD
Entacapone—Dysphagia—Thalidomide—leprosy	0.00523	0.00523	CcSEcCtD
Entacapone—Angina pectoris—Thalidomide—leprosy	0.00509	0.00509	CcSEcCtD
Entacapone—Upper respiratory tract infection—Thalidomide—leprosy	0.00486	0.00486	CcSEcCtD
Entacapone—Pollakiuria—Thalidomide—leprosy	0.00483	0.00483	CcSEcCtD
Entacapone—Erectile dysfunction—Thalidomide—leprosy	0.00481	0.00481	CcSEcCtD
Entacapone—Weight increased—Thalidomide—leprosy	0.00476	0.00476	CcSEcCtD
Entacapone—Gastrointestinal pain—Dapsone—leprosy	0.00475	0.00475	CcSEcCtD
Entacapone—Weight decreased—Thalidomide—leprosy	0.00473	0.00473	CcSEcCtD
Entacapone—Hyperglycaemia—Thalidomide—leprosy	0.00471	0.00471	CcSEcCtD
Entacapone—Pneumonia—Thalidomide—leprosy	0.00469	0.00469	CcSEcCtD
Entacapone—Depression—Thalidomide—leprosy	0.00465	0.00465	CcSEcCtD
Entacapone—Acute coronary syndrome—Thalidomide—leprosy	0.00459	0.00459	CcSEcCtD
Entacapone—Abdominal pain—Dapsone—leprosy	0.00459	0.00459	CcSEcCtD
Entacapone—Body temperature increased—Dapsone—leprosy	0.00459	0.00459	CcSEcCtD
Entacapone—Myocardial infarction—Thalidomide—leprosy	0.00457	0.00457	CcSEcCtD
Entacapone—Neuropathy peripheral—Thalidomide—leprosy	0.00457	0.00457	CcSEcCtD
Entacapone—Conjunctivitis—Thalidomide—leprosy	0.00453	0.00453	CcSEcCtD
Entacapone—Sweating—Thalidomide—leprosy	0.00447	0.00447	CcSEcCtD
Entacapone—Haematuria—Thalidomide—leprosy	0.00444	0.00444	CcSEcCtD
Entacapone—Epistaxis—Thalidomide—leprosy	0.00439	0.00439	CcSEcCtD
Entacapone—Sinusitis—Thalidomide—leprosy	0.00437	0.00437	CcSEcCtD
Entacapone—Agranulocytosis—Thalidomide—leprosy	0.00435	0.00435	CcSEcCtD
Entacapone—Bradycardia—Thalidomide—leprosy	0.00426	0.00426	CcSEcCtD
Entacapone—Hepatitis—Thalidomide—leprosy	0.00418	0.00418	CcSEcCtD
Entacapone—Hypoaesthesia—Thalidomide—leprosy	0.00416	0.00416	CcSEcCtD
Entacapone—Pharyngitis—Thalidomide—leprosy	0.00415	0.00415	CcSEcCtD
Entacapone—Urinary tract disorder—Thalidomide—leprosy	0.00413	0.00413	CcSEcCtD
Entacapone—Urethral disorder—Thalidomide—leprosy	0.0041	0.0041	CcSEcCtD
Entacapone—Visual impairment—Thalidomide—leprosy	0.00403	0.00403	CcSEcCtD
Entacapone—Erythema multiforme—Thalidomide—leprosy	0.00395	0.00395	CcSEcCtD
Entacapone—Eye disorder—Thalidomide—leprosy	0.00391	0.00391	CcSEcCtD
Entacapone—Cardiac disorder—Thalidomide—leprosy	0.00388	0.00388	CcSEcCtD
Entacapone—Alopecia—Thalidomide—leprosy	0.0037	0.0037	CcSEcCtD
Entacapone—Vomiting—Dapsone—leprosy	0.00369	0.00369	CcSEcCtD
Entacapone—Mental disorder—Thalidomide—leprosy	0.00366	0.00366	CcSEcCtD
Entacapone—Malnutrition—Thalidomide—leprosy	0.00364	0.00364	CcSEcCtD
Entacapone—Headache—Dapsone—leprosy	0.00364	0.00364	CcSEcCtD
Entacapone—Flatulence—Thalidomide—leprosy	0.00359	0.00359	CcSEcCtD
Entacapone—Tension—Thalidomide—leprosy	0.00357	0.00357	CcSEcCtD
Entacapone—Dysgeusia—Thalidomide—leprosy	0.00357	0.00357	CcSEcCtD
Entacapone—Nervousness—Thalidomide—leprosy	0.00354	0.00354	CcSEcCtD
Entacapone—Back pain—Thalidomide—leprosy	0.00352	0.00352	CcSEcCtD
Entacapone—Muscle spasms—Thalidomide—leprosy	0.0035	0.0035	CcSEcCtD
Entacapone—Nausea—Dapsone—leprosy	0.00345	0.00345	CcSEcCtD
Entacapone—Vision blurred—Thalidomide—leprosy	0.00343	0.00343	CcSEcCtD
Entacapone—Tremor—Thalidomide—leprosy	0.00341	0.00341	CcSEcCtD
Entacapone—Ill-defined disorder—Thalidomide—leprosy	0.00338	0.00338	CcSEcCtD
Entacapone—Agitation—Thalidomide—leprosy	0.00335	0.00335	CcSEcCtD
Entacapone—Angioedema—Thalidomide—leprosy	0.00333	0.00333	CcSEcCtD
Entacapone—Malaise—Thalidomide—leprosy	0.00328	0.00328	CcSEcCtD
Entacapone—Vertigo—Thalidomide—leprosy	0.00327	0.00327	CcSEcCtD
Entacapone—Syncope—Thalidomide—leprosy	0.00326	0.00326	CcSEcCtD
Entacapone—Leukopenia—Thalidomide—leprosy	0.00326	0.00326	CcSEcCtD
Entacapone—Palpitations—Thalidomide—leprosy	0.00322	0.00322	CcSEcCtD
Entacapone—Loss of consciousness—Thalidomide—leprosy	0.0032	0.0032	CcSEcCtD
Entacapone—Cough—Thalidomide—leprosy	0.00318	0.00318	CcSEcCtD
Entacapone—Convulsion—Thalidomide—leprosy	0.00315	0.00315	CcSEcCtD
Entacapone—Hypertension—Thalidomide—leprosy	0.00314	0.00314	CcSEcCtD
Entacapone—Chest pain—Thalidomide—leprosy	0.0031	0.0031	CcSEcCtD
Entacapone—Myalgia—Thalidomide—leprosy	0.0031	0.0031	CcSEcCtD
Entacapone—Anxiety—Thalidomide—leprosy	0.00309	0.00309	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00308	0.00308	CcSEcCtD
Entacapone—Discomfort—Thalidomide—leprosy	0.00306	0.00306	CcSEcCtD
Entacapone—Dry mouth—Thalidomide—leprosy	0.00303	0.00303	CcSEcCtD
Entacapone—Confusional state—Thalidomide—leprosy	0.003	0.003	CcSEcCtD
Entacapone—Oedema—Thalidomide—leprosy	0.00297	0.00297	CcSEcCtD
Entacapone—Shock—Thalidomide—leprosy	0.00292	0.00292	CcSEcCtD
Entacapone—Nervous system disorder—Thalidomide—leprosy	0.00291	0.00291	CcSEcCtD
Entacapone—Thrombocytopenia—Thalidomide—leprosy	0.00291	0.00291	CcSEcCtD
Entacapone—Skin disorder—Thalidomide—leprosy	0.00289	0.00289	CcSEcCtD
Entacapone—Hyperhidrosis—Thalidomide—leprosy	0.00287	0.00287	CcSEcCtD
Entacapone—Anorexia—Thalidomide—leprosy	0.00283	0.00283	CcSEcCtD
Entacapone—Hypotension—Thalidomide—leprosy	0.00278	0.00278	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Thalidomide—leprosy	0.00271	0.00271	CcSEcCtD
Entacapone—Insomnia—Thalidomide—leprosy	0.00269	0.00269	CcSEcCtD
Entacapone—Paraesthesia—Thalidomide—leprosy	0.00267	0.00267	CcSEcCtD
Entacapone—Dyspnoea—Thalidomide—leprosy	0.00265	0.00265	CcSEcCtD
Entacapone—Somnolence—Thalidomide—leprosy	0.00264	0.00264	CcSEcCtD
Entacapone—Dyspepsia—Thalidomide—leprosy	0.00262	0.00262	CcSEcCtD
Entacapone—Decreased appetite—Thalidomide—leprosy	0.00258	0.00258	CcSEcCtD
Entacapone—Gastrointestinal disorder—Thalidomide—leprosy	0.00257	0.00257	CcSEcCtD
Entacapone—Fatigue—Thalidomide—leprosy	0.00256	0.00256	CcSEcCtD
Entacapone—Pain—Thalidomide—leprosy	0.00254	0.00254	CcSEcCtD
Entacapone—Constipation—Thalidomide—leprosy	0.00254	0.00254	CcSEcCtD
Entacapone—Feeling abnormal—Thalidomide—leprosy	0.00245	0.00245	CcSEcCtD
Entacapone—Gastrointestinal pain—Thalidomide—leprosy	0.00243	0.00243	CcSEcCtD
Entacapone—Urticaria—Thalidomide—leprosy	0.00236	0.00236	CcSEcCtD
Entacapone—Abdominal pain—Thalidomide—leprosy	0.00235	0.00235	CcSEcCtD
Entacapone—Body temperature increased—Thalidomide—leprosy	0.00235	0.00235	CcSEcCtD
Entacapone—Hypersensitivity—Thalidomide—leprosy	0.00219	0.00219	CcSEcCtD
Entacapone—Asthenia—Thalidomide—leprosy	0.00213	0.00213	CcSEcCtD
Entacapone—Pruritus—Thalidomide—leprosy	0.0021	0.0021	CcSEcCtD
Entacapone—Diarrhoea—Thalidomide—leprosy	0.00203	0.00203	CcSEcCtD
Entacapone—Dizziness—Thalidomide—leprosy	0.00196	0.00196	CcSEcCtD
Entacapone—Vomiting—Thalidomide—leprosy	0.00189	0.00189	CcSEcCtD
Entacapone—Rash—Thalidomide—leprosy	0.00187	0.00187	CcSEcCtD
Entacapone—Dermatitis—Thalidomide—leprosy	0.00187	0.00187	CcSEcCtD
Entacapone—Headache—Thalidomide—leprosy	0.00186	0.00186	CcSEcCtD
Entacapone—Nausea—Thalidomide—leprosy	0.00176	0.00176	CcSEcCtD
